← Back to headlines
Johnson & Johnson's Nipocalimab Approved for Use in China
Johnson & Johnson has announced that its drug nipocalimab has received approval for use in China.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
